Methodology of trials with antiemetics

Supportive Care in Cancer

Volumn 4, Issue 4, 1996, Pages 281-286

  Tonato, Maurizio ^a   Roila, Fausto ^a   Del Favero, Albano ^b   Ballatori, Enzo ^c  

^a Policlinico Hospital   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Antiemetics; Chemotherapy induced nausea; Delayed emesis

Indexed keywords

ANTIEMETIC AGENT;

CLINICAL TRIAL; HUMAN; METHODOLOGY; REVIEW;

ANTIEMETICS; CLINICAL TRIALS; HUMANS; RESEARCH DESIGN;

EID: 0030187120     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01358880     Document Type: Review

References (9)

1. Del Favero A, Roila F, Basurto C, et al (1991) Assessment of nausea. Eur J Clin Pharmacol 38:115-120
2. Gralla RJ, Clark RA, Kris MG, et al (1991) Methodology in anti-emetic trials. Eur J Cancer 27 [Suppl 1]:5-8
3. Italian Group for Antiemetic Research (1993) Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. J Clin Oncol 11:2396-2404
4. Italian Group for Antiemetic Research (1994) Cisplatin-induced delayed emesis: pattern and prognostic factors during three subsequent cycles. Ann Oncol 5:585-589
5. Italian Group for Antiemetic Research (1995) Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. J Clin Oncol 13:2417-2426
6. Italian Group for Antiemetic Research (1995) Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis. Ann Oncol 6:805-810
7. Kris MG, Pisters KMW, Hinkley L (1994) Delayed emesis following anticancer chemotherapy. Support Care Cancer 2:297-300
8. Olver IN (1992) Antiemetic trials: methodological considerations. In: Diaz Rubio E, Martin M (eds) Antiemetic therapy: current status and future prospects. Creaciones Elba, Madrid, pp 81-94
9. Tonato M, Roila F, Del Favero A (1991) Methodology of antiemetic trials: a review. Ann Oncol 2:107-114